Literature DB >> 8732199

Immunology of the Schwann cell.

P J Armati1, J D Pollard.   

Abstract

The Schwann cell or its myelin membrane appears to be the focus of autoimmune attack in several peripheral neuropathies. Potential Schwann cell antigens have therefore been extensively studied. Of the known Schwann cell proteins, MBP, P2, MAG, PLP, PO, PMP-22 and Connexin 32, gene defects of the latter three have recently been shown to be responsible for some forms of hereditary sensory and motor neuropathies. The L2/HNK-1 epitope, common to MAG, Po and PMP-22, is the target of autoantibody damage in neuropathies associated with certain IgM paraproteinaemias. P2, the inciting antigen in rat EAN, has no demonstrated role in human neuropathies. The same appears true for the glycolipid galactocerebroside, a neuritogen in rabbits. Gangliosides are currently under intense study, but the antigen for the common inflammatory neuropathies remains undefined. Evidence for the potential role of Schwann cells in immune modulation is provided; Schwann cells produced MHC molecules, the adhesion molecules I-CAM1, L1, L2-HNK-1, Ng-CAM, N-cadherisn, the cytokines IL-1, IL-6 and TNF-alpha and the inflammatory prostanoids, PGE-2 AND TxA2.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8732199

Source DB:  PubMed          Journal:  Baillieres Clin Neurol        ISSN: 0961-0421


  3 in total

Review 1.  The role of cytokines in Guillain-Barré syndrome.

Authors:  Ming-Ou Lu; Jie Zhu
Journal:  J Neurol       Date:  2010-11-23       Impact factor: 4.849

2.  TNF-alpha as an autocrine mediator and its role in the activation of Schwann cells.

Authors:  Yongwei Qin; Chun Cheng; Haibo Wang; Xiaoyi Shao; Yongjing Gao; Aiguo Shen
Journal:  Neurochem Res       Date:  2008-01-17       Impact factor: 3.996

3.  Erythropoietin enhances nerve repair in anti-ganglioside antibody-mediated models of immune neuropathy.

Authors:  Gang Zhang; Helmar C Lehmann; Nataliia Bogdanova; Tong Gao; Jiangyang Zhang; Kazim A Sheikh
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.